| Developing a synagis clinic for respiratory syncytial virus prophylaxis. | |
| | |
MedLine Citation:
|
PMID: 11552574 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
Respiratory Syncytial Virus (RSV) can be devastating to premature infants and children with chronic lung disease. Palivizumab (Synagis) is a monoclonal antibody that is administered monthly by injection to prevent RSV infection in infants at high risk. This article describes a nurse-run ambulatory clinic to provide RSV prophylaxis. Coordination with other agencies, including community neonatal intensive care units, was essential to the clinic's success. For each of its first 2 years of operation, 24 infants and their families attended the clinic once each month for 5 months throughout the RSV season. Outcomes for this patient population were compared to outcomes reported in the literature, and include reduced RSV-related hospitalizations and reduced days of hospitalization. |
| | |
Authors:
|
S Coffman; J Peck; C S Rasmussen |
Related Documents
:
|
12904604 - Pulmonary surfactant disaturated-phosphatidylcholine (dspc) turnover and pool size in n... 1484754 - Delayed compliance increase in infants with respiratory distress syndrome following syn... 15765744 - Relationship between atopic status and nasal interleukin 10 and 11 levels in infants wi... 20337964 - Lower interleukin-8 levels in airway aspirates from breastfed infants with acute bronch... 920164 - Influence of oral lysozyme administration on serum immunoglobulin and intestinal secret... 17285424 - The outcome of preterm neonates with intraventricular hemorrhage delivered with intrave... |
Publication Detail:
|
Type: Journal Article |
Journal Detail:
|
Title: MCN. The American journal of maternal child nursing Volume: 26 ISSN: 0361-929X ISO Abbreviation: MCN Am J Matern Child Nurs Publication Date: 2001 Sep-Oct |
Date Detail:
|
Created Date: 2001-09-12 Completed Date: 2001-10-04 Revised Date: 2007-10-29 |
Medline Journal Info:
|
Nlm Unique ID: 7605941 Medline TA: MCN Am J Matern Child Nurs Country: United States |
Other Details:
|
Languages: eng Pagination: 246-51; quiz 252 Citation Subset: IM; N |
Affiliation:
|
Sierra Health Services, Las Vegas, N.V. USA. scoffman@sierrahealth.com |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Ambulatory Care Facilities
/
organization & administration* Antibodies, Monoclonal / therapeutic use* Antiviral Agents / therapeutic use* Case Management / organization & administration Child Health Services / organization & administration* Humans Infant Infant, Newborn Infant, Premature Nevada Outcome Assessment (Health Care) Respiratory Syncytial Virus Infections / prevention & control* |
| Chemical | |
Reg. No./Substance:
|
0/Antibodies, Monoclonal; 0/Antiviral Agents; 0/palivizumab |
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Making evidence-based practice a reality in your institution.
Next Document: Teaching mothers about childhood immunizations.